EFTA00668688Set 9
2012-11-284p1,496w
marketing, distribution and sales in China of CicloMulsions and NeuroSTAT®.
NeuroVive will supply CicloMulsionr and NeuroSTAT® to Sihuan for clinical trials and, upon launch, will initially supply
commercial volumes ... launched.
Sihuan intends to conduct a Phase II/Ill clinical trial in China with CicloMulsionr for the treatment of reperfusion injury
following myocardial infarction based on the protocol being used
https://www.justice.gov/epstein/files/DataSet%209/EFTA00668688.pdf